Dianthus Therapeutics (DNTH) Misses Q2 EPS by 51c
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Join SI Premium – FREE
Dianthus Therapeutics (NASDAQ: DNTH) reported Q2 EPS of ($0.51).
For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Kanen Wealth Management urges Zevia to explore a sale
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
